Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
about
A mini-review on Biginelli adducts with notable pharmacological propertiesStructure of human Eg5 in complex with a new monastrol-based inhibitor bound in the R configurationSynthesis of sydnone substituted Biginelli derivatives as hyaluronidase inhibitors.Gold catalyzed cyclization of alkyne-tethered dihydropyrimidonesAn Automated Process for a Sequential Heterocycle/Multicomponent Reaction: Multistep Continuous Flow Synthesis of 5-(Thiazol-2-yl)-3,4-Dihydropyrimidin-2(1H)-ones.5-Acetyl-4-(2-chloro-phen-yl)-6-methyl-3,4-dihydro-pyrimidin-2(1H)-one5-Acetyl-4-(4-methoxy-phen-yl)-6-methyl-3,4-dihydro-pyrimidin-2(1H)-one.Ethyl 4-(4-hydroxy-phen-yl)-6-methyl-2-oxo-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate monohydrateEthyl 4-(4-chloro-phen-yl)-6-methyl-2-thioxo-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.5-Acetyl-4-(2-chloro-phen-yl)-6-methyl-3,4-dihydro-pyrimidine-2(1H)-thione.Ethyl (2Z)-2-(3-methoxy-benzyl-idene)-7-methyl-3-oxo-5-phenyl-2,3-dihydro-5H-1,3-thia-zolo[3,2-a]pyrimidine-6-carboxyl-ate.Ethyl 2-(2-acetoxy-benzyl-idene)-7-methyl-3-oxo-5-phenyl-2,3-dihydro-5H-1,3-thia-zolo[3,2-a]pyrimidine-6-carboxyl-ate.Biginelli reaction catalyzed by copper nanoparticlesEthyl 1,6-dimethyl-2-oxo-4-(quinolin-4-yl)-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.Primary Amine-Catalyzed Biginelli Reaction for the Enantioselective Synthesis of 3,4-Dihydropyrimidin-2(1H)-onesThe unexpected influence of aryl substituents in N-aryl-3-oxobutanamides on the behavior of their multicomponent reactions with 5-amino-3-methylisoxazole and salicylaldehydeEthyl 6-methyl-2-sulfanyl-idene-4-[4-(trifluoro-meth-yl)phen-yl]-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.Mining in New Caledonia: environmental stakes and restoration opportunities.Crystal structure of ethyl (2S)-9-meth-oxy-2-methyl-4-oxo-3,4,5,6-tetra-hydro-2H- 2,6-methano-benzo[g][1,3,5]oxa-diazocine-11-carboxyl-ate.Hydrogen-bonding 2D metal-organic solids as highly robust and efficient heterogeneous green catalysts for Biginelli reaction.Novel synthesis of a series of spiro 1,3-indanedione-fused dihydropyridines through the condensation of a tetrone with N-aryl/alkylenamines in presence of solid support silica sulfuric acid.Ethyl 4-(1,3-benzodioxol-5-yl)-6-methyl-2-sulfanylidene-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ateVanillic aldehydes for the one-pot synthesis of novel 2-oxo-1,2,3,4-tetrahydropyrimidines.Methyl (E)-2-[(3-chloro-4-cyano-phenyl)-imino]-4-(4-chloro-phen-yl)-6-methyl-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.The impact of microwave synthesis on drug discovery.Methyl 4-(4-chloro-phen-yl)-8-iodo-2-methyl-6-oxo-1,6-dihydro-4H-pyrimido[2,1-b]quinazoline-3-carboxyl-ate.Cationic dirhodium carboxylate-catalyzed synthesis of dihydropyrimidones from propargyl ureas.Ammonium Trifluoroacetate-Mediated Synthesis of 3,4-dihydropyrimidin-2(1H)-ones.Raman spectroscopy as a tool for monitoring mesoscale continuous-flow organic synthesis: Equipment interface and assessment in four medicinally-relevant reactions.Dihydropyrimidinone positive modulation of delta-subunit-containing gamma-aminobutyric acid type A receptors, including an epilepsy-linked mutant variant.Efficient synthesis of dihydropyrimidinones via a three-component Biginelli-type reaction of urea, alkylaldehyde and arylaldehyde.Crystal structure of methyl 4-(4-hy-droxy-phen-yl)-6-methyl-2-oxo-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate monohydrate.Recent progress in asymmetric Biginelli reaction.Advances in the design and discovery of drugs for the treatment of prostatic hyperplasia.Synergy, compatibility, and innovation: merging Lewis acids with stereoselective enamine catalysis.Metal-organic frameworks catalyzed C-C and C-heteroatom coupling reactions.The 'Ireland' one-pot alcohol oxidation coupling reactions: celebrating 30 years of diverse synthesis.Synthesis of diverse dihydropyrimidine-related scaffolds by fluorous benzaldehyde-based Biginelli reaction and post-condensation modifications.Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold.Methyl 4-(4-hy-droxy-phen-yl)-6-methyl-2-sulfanyl-idene-1,2,3,4-tetra-hydro-pyrimidine-5-carboxyl-ate.
P2860
Q26800023-1DCA7F0D-E29F-4897-9C36-5DA9E9F1F0FDQ27643649-3C8A8C2A-570D-46AF-B799-3B4C7117ACD5Q30352525-D7532ACF-FA48-4FEA-B9B0-FC665916F1AEQ33958635-C0B60544-1A77-4F46-8858-CD4DF9635E2EQ34185555-BC5773C4-1FF2-4755-BFF3-97DD58E3D598Q34225060-2E33C293-7B48-44DD-A156-C96EC54C4732Q34260258-41D3AE1B-2CBF-48D7-BB1D-3911F070BB55Q34266704-E2AA0F2A-5E6E-49D0-9334-20F87D7D5BD1Q34266910-A7C7F51F-5F33-4A58-A7BB-6CC9165F0314Q34272891-0D0B7400-EEEA-4C76-BD77-5F5C77928174Q34318494-2E5C282F-B620-4FD8-8075-37AB7ACAB8CAQ34319139-3AFE9D2F-DDB3-4BAF-B01B-E3D5711256B8Q34389248-B27CDE86-AFB7-4A54-A810-2168F9F9483AQ34428294-FB046283-2CF9-49B4-A2D5-73CAE157D4B9Q34433856-E4AF695C-320D-4D16-8079-441FE28088A4Q35030964-9FC97A84-77BC-4FC3-B655-8B9087180E6CQ35152855-11BF1F2A-FA66-41DB-81C3-827666C902E4Q35213696-67EE2105-A952-42DC-8B49-08B62566C76FQ35259987-477BC332-8748-4612-A4A3-22D8DC9CFAB4Q35469417-39D27419-DD37-492F-9030-2804C61BDD0DQ35584908-0B7A41EC-11DE-4D0E-9404-DA8CBC2724D6Q35638196-DC0809E6-6927-4455-B0A0-72A1D1E6D147Q35910028-46A781F6-B63A-486D-9997-05731ECAAB3CQ36314421-99044CCF-AC19-420C-82A5-47E0CFAE6C45Q36351705-71BB424F-2268-4A3B-908C-FD793FE289EBQ36656864-D249B11F-C7A9-42D5-B7D0-F4006063A9F2Q36950576-CC6AEDD3-1975-4A30-9FAF-1273E4A9BB68Q37156888-AD5189BF-0FE7-4384-A7F4-70D98D905894Q37186154-CCC2B3EA-35E7-476B-983F-202DED5FFB37Q37262520-FD5FBA07-DAE8-4ED8-8CAA-A05A16E841C9Q37406262-1845DA2B-6271-4AD6-A5A6-A4287DA319FDQ37432499-3255D49D-0505-4F7B-9EE4-B93A3D14ACB6Q38099250-CF2CA0A3-4224-4331-913F-547D88B15694Q38105608-0C478850-93F7-49C7-A9EB-1C4A603D62FBQ38200074-7B48E51C-78FC-4725-B4A4-AED3698436C9Q38327206-CCD29EA3-4A56-46FD-A1BD-596AE84D5265Q38554994-CD54DE44-FACA-4C14-9605-9A8E9B205D7CQ38586663-0B6F1F3C-2DFE-48ED-8D54-4337A3ADD6FAQ38912429-1CA31C2F-E911-476F-A21A-BD74E9A7DD14Q38944917-5514B797-D5BE-4020-82B7-DD302E1AF53F
P2860
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@ast
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@en
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@nl
type
label
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@ast
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@en
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@nl
prefLabel
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@ast
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@en
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@nl
P1476
Biologically active dihydropyrimidones of the Biginelli-type--a literature survey.
@en
P2093
P304
P356
10.1016/S0223-5234(00)01189-2
P577
2000-12-01T00:00:00Z